Related Experiment Video
Updated: Apr 27, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.7K
Reply to "the limitations of theoretical dose modeling for yttrium-90 radioembolization"
Daniel Y Sze1, Marnix G E H Lam2
1Division of Interventional Radiology, Stanford University, Stanford, California.
Journal of Vascular and Interventional Radiology : JVIR
|June 28, 2014
Abstract
No abstract available in PubMed .

